Quality assessment of 2705 treatment plans in the randomised Danish Breast Cancer Group Skagen trial 1
A high degree of protocol compliance was documented in the DBCG Skagen trial 1. No differences were observed among the treatment plans in the two randomisation arms.
Authors
- K. Boye (ORCID: https://orcid.org/0000-0002-7135-9577)
- Mette S. Thomsen (ORCID: https://orcid.org/0000-0002-6675-7781)
- Kjell Ivar Dybvik
- Simon Long Krogh
- Maj‐Britt Jensen (ORCID: https://orcid.org/0000-0001-5348-3040)
- Carine Kirkove (ORCID: https://orcid.org/0009-0005-8329-7229)
- Birgitte Vrou Offersen (ORCID: https://orcid.org/0000-0001-7356-2096)
- Line Bjerregaard Stick (ORCID: https://orcid.org/0000-0002-9630-3238)
- Sebastian Makocki
- Ebbe Laugaard Lorenzen (ORCID: https://orcid.org/0000-0003-1895-733X)
- I. Jensen
- Jan Alsner (ORCID: https://orcid.org/0000-0002-5395-3193)
- Martin Berg (ORCID: https://orcid.org/0000-0001-6943-3267)
- Esben Svitzer Yates
- Melanie Hasler
- Mette Nielsen
- Knud Andersen
- P. Schilling
- Veronika Tømmerås
Institutions
- Cliniques Universitaires Saint-Luc (BE)
- University of Southern Denmark (DK)
- Aalborg University Hospital (DK)
- Stavanger University Hospital (NO)
- Odense University Hospital (DK)
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
- Region of Southern Denmark (DK)
- Danish Breast Cancer Cooperative Group (DK)
- Corewell Health Zeeland Hospital (US)
- University Hospital Carl Gustav Carus (DE)
- Sørlandet Sykehus (NO)
- UiT The Arctic University of Norway (NO)
Publication Details
- Journal
- Radiotherapy and Oncology
- Published
- 2025-09-16
- DOI
- https://doi.org/10.1016/j.radonc.2025.111142
- Citations
- 5
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.68